Foundry Partners, LLC Alkermes Plc. Transaction History

Foundry Partners, LLC

  • $1.92 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024
BUY
$23.21 - $27.24 $50,040 - $58,729
2,156 Added 1.51%
144,627 $3.49 Million
Q1 2024

May 08, 2024
BUY
$26.4 - $32.56 $3.76 Million - $4.64 Million
142,471 New
142,471 $3.86 Million
Q2 2021

Jul 23, 2021
SELL
$18.78 - $25.15 $533,671 - $714,687
-28,417 Closed
0 $0
Q1 2021

May 12, 2021
BUY
$18.21 - $23.2 $517,473 - $659,274
28,417 New
28,417 $531,000

Others Institutions Holding ALKS

# of Institutions
374
Shares Held
173M
Call Options Held
231K
Put Options Held
158K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $5.9B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Foundry Partners, LLC Portfolio

Follow Foundry Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foundry Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email